Our most recent article “A Regenerative Approach to Canine Osteoarthritis Using Allogeneic, Adipose-Derived Mesenchymal Stem Cells. Safety Results of a Long-Term Follow-Up” has been published in the Frontiers in Veterinary Science journal. In this study we aimed to further explore the safety and effectiveness of allogeneic mesenchymal stem cells for the treatment of joint degenerative diseases in dogs.

According to our results, 83% of 58 dogs suffering from osteoarthritis improved or maintained improvement in lameness. Side effects of the treatment manifested only as short-term local inflammation in 2 dogs and no other adverse effects were documented. Our study demonstrated that the use of allogeneic mesenchymal stem cells (ADStem) provides a long-term effect and is a safe way of improving osteoarthritis symptoms in dogs.

The article can be accessed here.